System for monitoring and delivering medication to a patient and method of using the same to minimize the risks associated with automated therapy
A system and method for monitoring and delivering medication to a patient. The system includes a controller that has a control algorithm and a closed loop control that monitors the control algorithm. A sensor is in communication with the controller and monitors a medical condition. A rule based application in the controller receives data from the sensor and the closed loop control and compares the data to predetermined medical information to determine the risk of automation of therapy to the patient. A system monitor is also in communication with the controller to monitor system, remote system, and network activity and conditions. The controller then provides a predetermined risk threshold where below the predetermined risk threshold automated closed loop medication therapy is provided. If the predetermined risk threshold is met or exceeded, automated therapy adjustments may not occur and user/clinician intervention is requested.
1. A system for operating an infusion system, the system comprising one or more hardware processors configured to:
communicate with a controller of a pump, said pump configured to deliver a drug to a patient according to a first infusion rate;
detect a failure in a first channel of an infusion system;
determine a first risk of stopping delivery of the drug in view of the detected failure; and
determine, based on the first risk, whether to continue delivery of the drug or deliver another drug according a second infusion rate on a second channel different than the first channel, wherein the second infusion rate is different than the first infusion rate.
2. The system of claim 1 , wherein the drug is glucose.
3. The system of claim 1 , wherein the drug is dextrose.
4. The system of claim 1 , wherein the failure comprises air in an infusion line.
5. The system of claim 1 , wherein the failure comprises occlusion of an infusion line.
6. The system of claim 1 , wherein the one or more hardware processors are configured to deliver the drug at a predetermined rate after the detected failure.
7. The system of claim 1 , wherein the one or more hardware processors are configured to notify a remote system based on the detected failure.
8. The system of claim 1 , wherein the first risk is determined on a supervisory computing system that is independent from the infusion system.
9. The system of claim 1 , wherein the one or more hardware processors are configured to completely stop delivery of the drug based on the determination indicating that the first risk of stopping is lower than a second risk corresponding to the detected failure.
10. A method for operating an infusion system, the method comprising:
controlling a pump that is configured to deliver a drug to a patient according to a first infusion rate;
communicating with a controller of a pump, said pump configured to deliver a drug to a patient according to a first infusion rate;
detecting a failure in a first channel of an infusion system;
determining a first risk of stopping delivery of the drug in view of the detected failure; and
determining, based on the first risk, whether to continue delivery of the drug or deliver another drug according a second infusion rate on a second channel different than the first channel, wherein the second infusion rate is different than the first infusion rate.
11. The method of claim 10 , wherein the drug is insulin.
12. The method of claim 10 , wherein the drug is dextrose.
13. The method of claim 10 , wherein the first failure comprises air in an infusion line.
14. The method of claim 10 , wherein the first failure comprises occlusion of an infusion line.
15. The method of claim 10 , further comprising delivering the drug at a predetermined rate after the detected failure.
16. The method of claim 10 , further comprising notifying a clinician system based on the detected failure.
17. The method of claim 10 , wherein the first risk is determined on a supervisory computing system that is independent from the infusion system.
18. The method of claim 10 , further comprising completely stopping delivery of the drug based on the determination indicating that the first risk of stopping is lower than a second risk corresponding to the detected failure.